Coyne Terrance P.
SEC insider (Form 3/4/5 filer). CIK 0001814876. EVP & CFO at Royalty Pharma plc (RPRX). 44 reported Form 4/5 transactions since Sep 2024; latest on Aug 13, 2026. Located in NEW YORK, NY.
Companies Coyne Terrance P. has filed insider reports for
- Royalty Pharma plc (RPRX): Officer, EVP & CFO
Coyne Terrance P.
CIK: 0001814876
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Royalty Pharma plc
Discretionary Trading P&L
Holdings
Transaction History (44 total)
- Aug 13, 2026RPRX
Royalty Pharma plc
SaleIndirect9.2K shares at avg. $58.59$541K - Aug 13, 2026RPRX
Royalty Pharma plc
SaleIndirect1.8K shares at avg. $59.14$105K - Aug 7, 2026RPRX
Royalty Pharma plc
GiftIndirectClass E Ordinary Shares
18.5K shares- - Aug 5, 2026RPRX
Royalty Pharma plc
AwardIndirect11K shares- - May 26, 2026RPRX
Royalty Pharma plc
SaleIndirect64.4K shares at avg. $53.98$3.5M - May 6, 2026RPRX
Royalty Pharma plc
AwardIndirect24.3K shares- - Apr 28, 2026RPRX
Royalty Pharma plc
SaleIndirect1.9K shares at avg. $49.78$93K - Apr 28, 2026RPRX
Royalty Pharma plc
SaleIndirect32.9K shares at avg. $49.78$1.6M - Apr 1, 2026RPRX
Royalty Pharma plc
SaleIndirect1.9K shares at avg. $48.33$91K - Apr 1, 2026RPRX
Royalty Pharma plc
SaleIndirect32.9K shares at avg. $48.33$1.6M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 13, 2026 | RPRX Royalty Pharma plc | Sale | 9,230 | $58.59 | $540,752 | Indirect |
| Aug 13, 2026 | RPRX Royalty Pharma plc | Sale | 1,772 | $59.14 | $104,799 | Indirect |
| Aug 7, 2026 | RPRX Royalty Pharma plc | Gift Class E Ordinary Shares | 18,500 | - | - | Indirect |
| Aug 5, 2026 | RPRX Royalty Pharma plc | Award | 11,002 | - | $0 | Indirect |
| May 26, 2026 | RPRX Royalty Pharma plc | Sale | 64,399 | $53.98 | $3,476,116 | Indirect |
| May 6, 2026 | RPRX Royalty Pharma plc | Award | 24,263 | - | $0 | Indirect |
| Apr 28, 2026 | RPRX Royalty Pharma plc | Sale | 1,875 | $49.78 | $93,335 | Indirect |
| Apr 28, 2026 | RPRX Royalty Pharma plc | Sale | 32,916 | $49.78 | $1,638,506 | Indirect |
| Apr 1, 2026 | RPRX Royalty Pharma plc | Sale | 1,875 | $48.33 | $90,622 | Indirect |
| Apr 1, 2026 | RPRX Royalty Pharma plc | Sale | 32,916 | $48.33 | $1,590,890 | Indirect |
1-10 of 44 transactions